Clinical update
Quick Hit: AF care quality moves from a checklist to a care pathway
The 2026 AHA/ACC atrial-fibrillation performance and quality measures put initial evaluation, stroke-risk documentation, prevention, equity, and shared decisions into one visible care-quality framework.
- Prepared by
- Iraq Cardiology Editorial Team
- Source authors
- Benjamin EJ, Marcus GM, Hess PL, et al.
- Last reviewed
- August 23, 2026
- Reading time
- 4 min
Quick summary
The essential point, in one sentence.
Reading companion
A professional question, bounded to this record.
Answers use this update and its recorded sources only; it does not provide individual treatment advice.
What is new
The 2026 AHA/ACC document sets out **five performance measures** and **16 quality measures** for atrial fibrillation care. It is designed to help clinical teams and health systems assess care processes and identify opportunities for improvement.
The practical signal
The framework keeps the first clinical evaluation visible, including structured assessment, stroke-risk documentation, and anticoagulation when indicated. It also extends beyond a medication checklist by including prevention, health equity, shared decision-making, and selected rhythm-control pathways.
Why this matters to a team
Quality measures can make the care pathway discussable: what is consistently documented, where a handoff becomes unclear, and which patients may be missing a structured review. That is different from using a metric as a substitute for individual clinical judgement.
Clinical boundary
This is a quality-improvement framework, not a patient-specific treatment instruction. Application should remain aligned with current guidance, local protocols, available services, and the individual clinical context.
Source
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation.
Professional discussion starter
Turn reading into a balanced conversation.
Prompts for professional reflection—not individual treatment advice.
- 1Which element of the source most changes how your team would frame Atrial fibrillation care quality?
- 2Which limitation or context should be made explicit before discussing application?
- 3What question is worth taking to a journal club or multidisciplinary meeting?
Continue reading
Related updates
Clinical update
When a Coronary Stent Fails: Can Stentectomy Offer a Way Forward?
A new review suggests that catheter-based removal of a fully deployed coronary stent may be feasible in carefully selected cases of complex stent failure — but only within a highly specialized, imaging-led strategy.
Read updateClinical update
Quick Hit: Lp(a) enters the standard lipid conversation
The 2026 ACC/AHA dyslipidemia guideline recommends measuring lipoprotein(a) at least once in adults as part of ASCVD risk assessment—an update that broadens the prevention conversation beyond LDL-C alone.
Read update